Comparative effectiveness and implementation research: Directions for neurology

Annals of Neurology

Volumn 71, Issue 6, 2012, Pages 732-742

  Vickrey, Barbara G ^a,b   Hirtz, Deborah ^c   Waddy, Salina ^c   Cheng, Eric M ^a,b   Johnston, S Claiborne ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; DABIGATRAN; ETHOSUXIMIDE; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TISSUE PLASMINOGEN ACTIVATOR; VALPROIC ACID;

CAROTID ARTERY STENTING; CAROTID ENDARTERECTOMY; CHILDHOOD ABSENCE EPILEPSY; CLINICAL PRACTICE; CLINICAL RESEARCH; COMPARATIVE EFFECTIVENESS; ELECTRONIC MEDICAL RECORD; ETHNIC DIFFERENCE; EVIDENCE BASED PRACTICE; FOCAL EPILEPSY; GRAND MAL SEIZURE; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH DISPARITY; HEALTH SERVICE; HUMAN; META ANALYSIS; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCIENTIFIC LITERATURE; SOCIOECONOMICS; STROKE; STUDY DESIGN; SYSTEMATIC REVIEW (TOPIC); TRANSLATIONAL RESEARCH;

BIOMEDICAL RESEARCH; COMPARATIVE EFFECTIVENESS RESEARCH; COST-BENEFIT ANALYSIS; HUMANS; META-ANALYSIS AS TOPIC; NERVOUS SYSTEM DISEASES; NEUROLOGY; OBSERVATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84862751281     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22672     Document Type: Review

References (66)

1. Lauer MS, Collins FS. Using science to improve the nation's health system: NIH's commitment to comparative effectiveness research. JAMA 2010;303:2182-2183.
2. Congressional Budget Office. Research on the comparative effectiveness of medical treatment: issues and options for an expanded federal role. Washington, DC: Congressional Budget Office, 2007.
3. Westfall JM, Mold J, Fagnan L. Practice-based research - "Blue Highways" on the NIH roadmap. JAMA 2007;297:403-406.
4. Institute of Medicine. Initial national priorities for comparative effectiveness research. Washington, DC: National Academies Press, 2009.
5. Patient Protection and Affordable Care Act, 23. Available at: http://frwebgate.access.gpo.gov/cgibin/getdoc.cgi?dbname=111-cong- bills&docid=f:h3590enr.txt.pdf Accessed September 23, 2011.
6. Comparative Effectiveness Research Key Function Committee. Available at: http://www.ctsaweb.org/index.cfm?fuseaction=committee.viewCommittee&com-ID= 1221&abbr=CERKFC Accessed September 23, 2011.
7. Collins FS. Research agenda. Opportunities for research and NIH. Science 2010;327:36-37.
8. National Institute of Neurological Disorders and Stroke. Strategic priorities and principles. Available at: http://www.ninds.nih.gov/about-ninds/ plans/NINDS-strategic-plan.htm Accessed May 3, 2011.
9. Horn SD, Gassaway J. Practice-based evidence study design for comparative effectiveness research. Med Care 2007;45(10 suppl 2):S50-S57.
10. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145-151.
11. Glauser TA, Cnaan A, Shinnar S, et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med 2010;362:790-799.
12. O'Connor AB. Building comparative efficacy and tolerability into the FDA approval process. JAMA 2010;303:979-980.
13. Johnston SC, Hauser SL. IOM task impossible: set the agenda for neurological comparative effectiveness research. Ann Neurol 2009;66:A4-A6.
14. Sung NS, Crowley WF Jr, Genel M, et al. Central challenges facing the national clinical research enterprise. JAMA 2003;289:1278-1287.
15. King G, William DR. Race and health: a multi-dimensional approach to African-American health. In: Amick BC, Levine S, Tarlov AR, Walsh DC, eds. Society and health. New York, NY: Oxford University Press, 1995:93-130.
16. Institute of Medicine. Unequal treatment: confronting racial and ethnic disparities in health care. Washington, DC: The National Academies Press, 2003.
17. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA 1999;281:2305-2315.
18. Cooper LA, Hill MN, Powe NR. Designing and evaluating interventions to eliminate racial and ethnic disparities in health care. J Gen Intern Med 2002;17:477-486.
19. Stansbury JP, Jia H, Williams LS, et al. Ethnic disparities in stroke: epidemiology, acute care, and postacute outcomes. Stroke 2005;36:374-386.
20. Burneo JG, Jette N, Theodore W, et al. Disparities in epilepsy: report of a systematic review by the North American Commission of the International League Against Epilepsy. Epilepsia 2009;50:2285-2295.
21. Kenneson A, Vatave A, Finkel R. Widening gap in age at muscular dystrophy-associated death between blacks and whites, 1986-2005. Neurology 2010;75:982-989.
22. Dromerick AW, Gibbons MC, Edwards DF, et al. Preventing recurrence of thromboembolic events through coordinated treatment in the District of Columbia. Int J Stroke 2011;6:454-460.
23. Cheng EM, Cunningham WE, Towfighi A, et al. Randomized controlled trial of an intervention to enable stroke survivors throughout the Los Angeles County safety net to "Stay With the Guidelines." Circ Cardiovasc Qual Outcomes 2011;4:229-234.
24. National Institute of Neurological Disorders and Stroke. Report from the strategic planning advisory panel on health disparities. Available at: http://www.ninds.nih.gov/about-ninds/plans/NINDS-health-disparities-report.htm Accessed May 3, 2011.
25. Antman EM, Lau J, Kupelnick B, et al. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA 1992;268:240-248.
26. Ioannidis JP, Cappelleri JC, Lau J. Meta-analyses and large randomized, controlled trials. N Engl J Med 1998;338:59; author reply 61-62.
27. Greener J, Enderby P, Whurr R. Speech and language therapy for aphasia following stroke. Cochrane Database Syst Rev 2000;(2):CD000425.
28. Bhogal SK, Teasell R, Speechley M. Intensity of aphasia therapy, impact on recovery. Stroke 2003;34:987-993.
29. Brott TG, Hobson RW Jr, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010;363:11-23.
30. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-1151.
31. Sacco RL, Diener H-C, Yusuf S, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008;359:1238-1251.
32. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1000-1015.
33. Campbell MK, Elbourne DR, Altman DG. CONSORT statement: extension to cluster randomised trials. BMJ 2004;328:702-708.
34. Meurer WJ, Frederiksen SM, Majersik JJ, et al. Qualitative data collection and analysis methods: the INSTINCT trial. Acad Emerg Med 2007;14:1064-1071.
35. Magid DJ, Shetterly SM, Margolis KL, et al. Comparative effectiveness of angiotensin-converting enzyme inhibitors versus beta-blockers as second-line therapy for hypertension. Circ Cardiovasc Qual Outcomes 2010;3:453-458.
36. Selby JV, Fireman BH, Lundstrom RJ, et al. Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. N Engl J Med 1996;335:1888-1896.
37. Chimowitz MI, Kokkinos J, Strong J, et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995;45:1488-1493.
38. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305-1316.
39. Bibbins-Domingo K, Chertow GM, Coxson PG, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010;362:590-599.
40. Matchar DB, Samsa GP, Matthews JR, et al. The Stroke Prevention Policy Model: linking evidence and clinical decisions. Ann Intern Med 1997;127(8 pt 2):704-711.
41. Agency for Healthcare Research and Quality. EPC topic nomination and selection (on-line). Available at: http://www.ahrq.gov/clinic/epc/epctopicn.htm Accessed May 3, 2011.
42. Berg AO. The CDC's EGAPP initiative: evaluating the clinical evidence for genetic tests. Am Fam Physician 2009;80:1218.
43. Cochrane Collaboration. Available at: http://www.cochrane.org. Accessed May 3, 2011.
44. Gliklich RE, Dreyer NA (eds). Registries for evaluating patient outcomes: a user's guide. 2nd ed. AHRQ Publication No. 10-EHC049. Rockville, MD: Agency for Healthcare Research and Quality, 2010.
45. Jackson CE, Lovitt S, Gowda N, et al. Factors correlated with NPPV use in ALS. Amyotroph Lateral Scler 2006;7:80-85.
46. Fonarow GC, Reeves MJ, Smith EE, et al. Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. Circ Cardiovasc Qual Outcomes 2010;3:291-302.
47. Agency for Healthcare Research and Quality. Electronic newsletter, December 10, 2010. Available at: http://www.ahrq.gov/news/enews/enews301.htm#1 Accessed May 3, 2011.
48. Shah SA, Smith JK, Li Y, et al. Underutilization of therapy for hepatocellular carcinoma in the Medicare population. Cancer 2011; 117:1019-1026.
49. Society of General Internal Medicine. Dataset compendium. Available at: http://www.sgim.org/index.cfm?pageId=760 Accessed October 13, 2011.
50. Vermont Oxford Network. Available at: http://www.vtoxford.org Accessed May 3, 2011.
51. Dahodwala N, Meyer A-C. Emerging subspecialties in neurology: health services research. Neurology 2010;74:e37-e39.
52. United States Department of Veterans Affairs. VA HSR&D Research Career and Development Program. Available at: http://www.hsrd.research.va.gov/ funding/cdp Accessed October 13, 2011.
53. Selker HP, Strom BL, Ford DE, et al. White paper on CTSA consortium role in facilitating comparative effectiveness research: September 23, 2009 CTSA consortium strategic goal committee on comparative effectiveness research. Clin Transl Sci 2010;3:29-37.
54. Brook RH. Possible outcomes of comparative effectiveness research. JAMA 2009;302:194-195.
55. Patient-Centered Outcomes Research Institute. Report to the PCORI Board. Available at: http://www.pcori.org/images/PDC-Report-2011-05-16.pdf Accessed October 13, 2011.
56. National Heart Lung and Blood Institute. Division of prevention and population sciences strategic plan. Available at: http://www.nhlbi.nih.gov/ about/dpps/strategicplan.htm#goal2 Accessed May 3, 2011.
57. PAR 10-038: Dissemination and implementation research in health (R01). Available at: http://grants.nih.gov/grants/guide/pa-files/PAR-10-038.html Accessed May 3, 2011.
58. Stetler CB, Mittman BS, Francis J. Overview of the VA Quality Enhancement Research Initiative (QUERI) and QUERI theme articles: QUERI Series. Implement Sci 2008;3:8.
59. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ 1995;311:376-380.
60. Gillum LA, Gouveia C, Dorsey ER, et al. NIH disease funding levels and burden of disease. PLoS One 2011;6:e16837.
61. National Institute of Neurological Disorder and Stroke. Report from Strategic Planning Advisory Panel on Health Disparities. Available at: http://www.ninds.nih.gov/about-ninds/plans/NINDS-health-disparities-report.htm Accessed May 4, 2011.
62. National Institutes of Health. Actual obligations by institute and center FY 1998 - FY 2010. Available at: http://officeofbudget.od.nih.gov/pdfs/FY12/ Actual%20Obligations%20by%20IC%201998-2010.pdf Accessed October 13, 2011.
63. Patient-Centered Outcomes Research Institute. Available at: http://www.pcori.org/ Accessed October 13, 2011.
64. Washington AE, Lipstein SH. The Patient-Centered Outcomes Research Institute-promoting better information, decisions, and health. N Engl J Med 2011;365:e31.
65. National Institutes of Health Research Portfolio Online Reporting Tools (RePORT). Project listing by category. Available at: http://report.nih.gov/rcdc/ categories/ProjectSearch.aspx?FY=2010&ARRA=N&DCat= Comparative%20Effectiveness%20Research Accessed September 21, 2011.
66. Paxton EW, Inacio MCS, Khatod M, et al. Kaiser Permanente National Total Joint Replacement Registry: aligning operations with information technology. Clin Orthop Relat Res 2010;468:2646-2663.